NCT00154063View on ClinicalTrials.gov

Efficacy and Safety Study of E2007 in Migraine Prophylaxis

PHASE2CompletedINTERVENTIONAL
Enrollment

206

Participants

Timeline

Start Date

January 31, 2005

Primary Completion Date

June 30, 2006

Study Completion Date

June 30, 2006

Conditions
Migraine Prophylaxis
Interventions
DRUG

E2007

OTHER

Placebo

Trial Locations (9)

10550

Elkind Headache Center, Mount Vernon

27401

Investigational Site, Greensboro

33407

Investigational Site, West Palm Beach

33606

Investigational Site, Tampa

60614

Investigational Site, Chicago

65807

Investigational Site, Springfield

77004

Investigational Site, Houston

90404

Investigational Site, Santa Monica

92056

Investigational Site, Oceanside

All Listed Sponsors
lead

Eisai Inc.

INDUSTRY

NCT00154063 - Efficacy and Safety Study of E2007 in Migraine Prophylaxis | Biotech Hunter | Biotech Hunter